Role of CD4⁺ T cells in a protective immune response against Cryptococcus neoformans in the central nervous system

References

• Lewis JL, Rabinovich S. The wide spectrum of cryptococcal infections. Am J Med 1972; 53: 315–322
   PubMed Web of Science ®Google Scholar
• Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med 1974; 80: 176–181
   PubMed Web of Science ®Google Scholar
• Gupta RK, Khan ZU, Nampoory MR, et al. Cutaneous cryptococcosis in a diabetic renal transplant recipient. J Med Microbiol 2004; 53: 445–449
   PubMedGoogle Scholar
• Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 533–538
   PubMed Web of Science ®Google Scholar
• Dev D, Basran GS, Slater D, et al. Immunodeficiency without HIV. Consider HIV negative immunodeficiency in cryptococcosis. BMJ 1994; 308: 1436
   PubMedGoogle Scholar
• Casadevall A, Perfect JR. Cryptococcus neoformans. ASM Press, Washington, DC 1998
   Google Scholar
• Kwon-Chung KJ. Cryptococcosis. Medical Mycology, KJ Kwon-Chung, JE Bennett. Lea & Febiger, Philadelphia 1992; 397–446
   Google Scholar
• Powderly WG. Therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1992; 14: S54–S59
   PubMed Web of Science ®Google Scholar
• Spitzer ED, Spitzer SG, Freundlich LF, Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 1993; 341: 595–596
   PubMed Web of Science ®Google Scholar
• Mukherjee J, Pirofski LA, Scharff MD, Casadevall A. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci USA 1993; 90: 3636–3640
   PubMed Web of Science ®Google Scholar
• Hobbs MM, Perfect JR, Granger DL, Durack DT. Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis. Infect Immun 1990; 58: 2115–2119
   PubMedGoogle Scholar
• Hill JO, Aguirre KM. CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans. J Immunol 1994; 152: 2344–2350
   PubMed Web of Science ®Google Scholar
• Aguirre K, Havell EA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995; 63: 1725–1731
   PubMed Web of Science ®Google Scholar
• Buchanan KL, Doyle HA. Requirement for CD4+ T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice. Infect Immun 2000; 68: 456–462
   PubMed Web of Science ®Google Scholar
• Uicker WC, Doyle HA, McCracken JP, et al. Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans. Medical Mycology 2005; 43: 27–38
   PubMed Web of Science ®Google Scholar
• Murphy JW, Cozad GC. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun 1972; 5: 896–901
   PubMed Web of Science ®Google Scholar
• Buchanan KL, Murphy JW. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect Immun 1993; 61: 2854–2865
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Strieter RM, Standiford TJ, et al. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol 1995; 155: 4790–4797
   PubMedGoogle Scholar
• Olszewski MA, Huffnagle GB, Traynor TR, et al. Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect Immun 2001; 69: 6256–6263
   PubMedGoogle Scholar
• Olszewski MA, Huffnagle GB, McDonald RA, et al. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J Immunol 2000; 165: 6429–6436
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Strieter RM, McNeil LK, et al. Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J Immunol 1997; 159: 318–327
   PubMed Web of Science ®Google Scholar
• Doyle HA, Murphy JW. MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J Leukoc Biol 1997; 61: 147–155
   PubMedGoogle Scholar
• Huffnagle GB, McNeil LK. Dissemination of C. neoformans to the central nervous system: role of chemokines, Th1 immunity and leukocyte recruitment. J Neurovirol 1999; 5: 76–81
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, McNeil LK, McDonald RA, et al. Cutting edge: role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol 1999; 163: 4642–4646
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Toews GB, Burdick MD, et al. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 1996; 157: 4529–4536
   PubMed Web of Science ®Google Scholar
• Kawakami K, Kohno S, Kadota J, et al. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-gamma and its protective effect against cryptococcal infection. Microbiol Immunol 1995; 39: 135–143
   PubMedGoogle Scholar
• Kawakami K, Kinjo Y, Yara S, et al. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Infect Immun 2001; 69: 6643–6650
   PubMedGoogle Scholar
• Kawakami K, Qureshi MH, Koguchi Y, et al. Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18. Cell Immunol 1999; 193: 9–16
   PubMedGoogle Scholar
• Kawakami K, Qureshi MH, Zhang T, et al. Interferon-gamma (IFN-gamma)-dependent protection and synthesis of chemoattractants for mononuclear leucocytes caused by IL-12 in the lungs of mice infected with Cryptococcus neoformans. Clin Exp Immunol 1999; 117: 113–122
   PubMedGoogle Scholar
• Kawakami K, Tohyama M, Teruya K, et al. Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol Med Microbiol 1996; 13: 123–130
   PubMedGoogle Scholar
• Bauman SK, Huffnagle GB, Murphy JW. Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun 2003; 71: 68–74
   PubMed Web of Science ®Google Scholar
• Ransohoff RM, Kivisakk P, Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003; 3: 569–581
   PubMed Web of Science ®Google Scholar
• Blasi E, Barluzzi R, Mazzolla R, et al. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J Neuroimmunol 1995; 58: 111–116
   PubMed Web of Science ®Google Scholar
• Lee SC, Kress Y, Dickson DW, Casadevall A. Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody. J Neuroimmunol 1995; 62: 43–52
   PubMed Web of Science ®Google Scholar
• Lee SC, Dickson DW, Brosnan CF, Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 1994; 180(1)365–369
   PubMed Web of Science ®Google Scholar
• Alspaugh JA, Granger DL. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun 1991; 59: 2291–2296
   PubMedGoogle Scholar
• Barluzzi R, Mazzolla R, Brozzetti A, et al. A low virulent strain of Candida albicans enhances brain anticryptococcal defenses: characterization of the local immune reaction by RT–PCR and histochemical analysis. J Neuroimmunol 1997; 79: 37–48
   PubMed Web of Science ®Google Scholar